Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - PRE-TAX INCOME
Pre-tax Income HALO - Halozyme Therapeutics, Inc.
348 M
LAST VALUE
18.39%
2 YEAR CAGR
44.80%
5 YEAR CAGR
19.96%
10 YEAR CAGR